This inventor holds 1 USPTO granted patent. Top assignees: Osaka Bioscience Institute, Teijin Limited. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2005
Title: The Innovations of Yosuke Kataoka in Neuropathy Remedies
Introduction: Yosuke Kataoka, an inventive mind based in Otsu, Japan, has made a significant contribution to the field of neurodegenerative disease treatment. With one patent to his name, he continues to push the boundaries of medical science and innovation.
Latest Patents: Kataoka's most notable patent is focused on neuropathy remedies. The invention provides a novel therapeutic agent for neurodegenerative diseases, incorporating active ingredients such as a (15R)-isocarbacycline derivative, as indicated by the chemical formula [I], or a 15-deoxy-isocarbacycline derivative represented by formula [III]. These compounds are defined wherein "R" denotes a C-C alkylene group, and "R" can be a hydrogen atom, a C-C alkyl group, or a protective group. This innovative approach addresses critical aspects of treating neurodegenerative conditions and could pave the way for new therapeutic options.
Career Highlights: Throughout his career, Yosuke Kataoka has worked with notable organizations including Teijin Limited and the Osaka Bioscience Institute. His professional journey has equipped him with valuable insights and expertise, prominently showcased in his inventions.
Collaborations: Kataoka has collaborated with talented individuals such as Yorimasa Suwa and Noboru Yoshioka. These partnerships have fostered an environment of creativity, enabling the development of groundbreaking solutions within the scientific community.
Conclusion: Yosuke Kataoka's dedication to the field of neuropathy remedies exemplifies the spirit of innovation. Through his patent and collaborative efforts, he has not only contributed to the scientific community but also holds the potential to improve countless lives through his groundbreaking work. His inventive spirit and commitment to research continue to influence advancements in neurodegenerative disease treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile